ReviewMedicine and pharmacy reports2022

Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review.

Daniel Sur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.